These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 1370335)
21. Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Learmont J; Tindall B; Evans L; Cunningham A; Cunningham P; Wells J; Penny R; Kaldor J; Cooper DA Lancet; 1992 Oct; 340(8824):863-7. PubMed ID: 1357294 [TBL] [Abstract][Full Text] [Related]
22. Curdlan sulfate and HIV-1. I. In vitro inhibitory effects of curdlan sulfate on HIV-1 infection. Aoki T; Kaneko Y; Stefanski MS; Nguyen T; Ting RC AIDS Res Hum Retroviruses; 1991 Apr; 7(4):409-15. PubMed ID: 1676899 [TBL] [Abstract][Full Text] [Related]
23. [Anti-HIV activities of Achyranthes bidentata polysaccharide sulfate in vitro and in vivo]. Peng ZG; Chen HS; Guo ZM; Dong B; Tian GY; Wang GQ Yao Xue Xue Bao; 2008 Jul; 43(7):702-6. PubMed ID: 18819473 [TBL] [Abstract][Full Text] [Related]
24. Killing of cryptococcus neoformans by Staphylococcus aureus: the role of cryptococcal capsular polysaccharide in the fungal-bacteria interaction. Saito F; Ikeda R Med Mycol; 2005 Nov; 43(7):603-12. PubMed ID: 16396245 [TBL] [Abstract][Full Text] [Related]
25. Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents. Passaes CPB; Bruel T; Decalf J; David A; Angin M; Monceaux V; Muller-Trutwin M; Noel N; Bourdic K; Lambotte O; Albert ML; Duffy D; Schwartz O; Sáez-Cirión A J Virol; 2017 Mar; 91(6):. PubMed ID: 28077644 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stage of disease. Gómez AM; Smaill FM; Rosenthal KL Clin Exp Immunol; 1994 Jul; 97(1):68-75. PubMed ID: 7518369 [TBL] [Abstract][Full Text] [Related]
27. Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. McElrath MJ; Pruett JE; Cohn ZA Proc Natl Acad Sci U S A; 1989 Jan; 86(2):675-9. PubMed ID: 2492110 [TBL] [Abstract][Full Text] [Related]
28. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences. Li XD; Moore B; Cloyd MW Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547 [TBL] [Abstract][Full Text] [Related]
29. Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells. De Maria A; Pantaleo G; Schnittman SM; Greenhouse JJ; Baseler M; Orenstein JM; Fauci AS J Immunol; 1991 Apr; 146(7):2220-6. PubMed ID: 1706390 [TBL] [Abstract][Full Text] [Related]
30. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines. Brack-Werner R; Kleinschmidt A; Ludvigsen A; Mellert W; Neumann M; Herrmann R; Khim MC; Burny A; Müller-Lantzsch N; Stavrou D AIDS; 1992 Mar; 6(3):273-85. PubMed ID: 1373627 [TBL] [Abstract][Full Text] [Related]
31. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). Rich EA; Chen IS; Zack JA; Leonard ML; O'Brien WA J Clin Invest; 1992 Jan; 89(1):176-83. PubMed ID: 1370293 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of HIV-1 infection by alkylureas. Goldstein H; Pettoello-Mantovani M; Kollmann TR; Calvelli TA; Rubinstein A AIDS; 1991 Dec; 5(12):1447-52. PubMed ID: 1726039 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of HIV-1 replication in H9 cells by nystatin-A compared with other antiviral agents. Selvam MP; Blay RA; Geyer S; Buck SM; Pollock L; Mayner RE; Epstein JS AIDS Res Hum Retroviruses; 1993 May; 9(5):475-81. PubMed ID: 7686387 [TBL] [Abstract][Full Text] [Related]
35. Antibodies reactive with the cryptococcal capsular polysaccharide glucuronoxylomannan are present in sera from children with and without human immunodeficiency virus infection. Abadi J; Pirofski La J Infect Dis; 1999 Sep; 180(3):915-9. PubMed ID: 10438394 [TBL] [Abstract][Full Text] [Related]
36. Sulfated colominic acid: an antiviral agent that inhibits the human immunodeficiency virus type 1 in vitro. Yang DW; Ohta Y; Yamaguchi S; Tsukada Y; Haraguchi Y; Hoshino H; Amagai H; Kobayashi I Antiviral Res; 1996 Jun; 31(1-2):95-104. PubMed ID: 8793013 [TBL] [Abstract][Full Text] [Related]
37. In vitro susceptibility of Thai seronegative donor CD8+ T lymphocytes to human immunodeficiency virus-1 (HIV-1) infection. Haponsaph R; Darden JM; Chantakulkij S; Sannoi N; de Souza MS; Brown AE; Birx DL; Polonis VR; Pattanapanyasat K Asian Pac J Allergy Immunol; 2004 Mar; 22(1):39-48. PubMed ID: 15366657 [TBL] [Abstract][Full Text] [Related]
38. The role of IL-15 in challenging Acquired Immunodeficiency Syndrome. d'Ettorre G; Andreotti M; Ceccarelli G; Galluzzo CM; Mallano A; Massetti AP; Tierno F; Stella S; Amici R; Vella S; Mastroianni CM; Vullo V Cytokine; 2012 Jan; 57(1):54-60. PubMed ID: 22055728 [TBL] [Abstract][Full Text] [Related]
39. [Cutaneous cryptococcosis in AIDS patient]. Gasiorowski J; Szybejko-Machaj G; Machaj A Pol Merkur Lekarski; 2001 Jun; 10(60):456-9. PubMed ID: 11503263 [TBL] [Abstract][Full Text] [Related]
40. HIV-1 infection of human CD4+ T cells in vitro. Differential induction of apoptosis in these cells. Martin SJ; Matear PM; Vyakarnam A J Immunol; 1994 Jan; 152(1):330-42. PubMed ID: 7902858 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]